Evoke Pharma Inc Working Capital to Net Assets Ratio
Evoke Pharma Inc working capital to net assets ratio. Evoke Pharma Inc (EVOK) has a Working Capital to Net Assets ratio of 98.0% as of September 2025. Working capital of $3.30 Million (current assets of $15.54 Million minus current liabilities of $12.24 Million) is measured against net assets of $3.36 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check how tangible is Evoke Pharma Inc's equity to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Evoke Pharma Inc (2011–2024)
Working capital to net assets ratio of Evoke Pharma Inc from 2011 to 2024. This chart shows how Evoke Pharma Inc's Working Capital to Net Assets ratio has evolved across 14 annual periods from 2011 to 2024. As of September 2025, the ratio stands at 98.0%, reflecting working capital of $3.30 Million against net assets of $3.36 Million USD. See defensive interval ratio of Evoke Pharma Inc to measure how many days the company can operate on defensive assets alone.
Evoke Pharma Inc Working Capital to Net Assets Ratio by Year (2011–2024)
Evoke Pharma Inc working capital to net assets ratio by year from 2011 to 2024. The table below presents the year-by-year Working Capital to Net Assets ratio for Evoke Pharma Inc from 2011 to 2024, covering 14 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Evoke Pharma Inc balance sheet assets.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 97.4% | $6.86 Million | $7.04 Million | $17.24 Million | $10.38 Million | ▼ -11.9 pp |
| 2023 | 109.4% | $-2.82 Million | $-2.58 Million | $6.83 Million | $9.65 Million | ▼ -137.1 pp |
| 2022 | 246.5% | $10.07 Million | $4.08 Million | $11.72 Million | $1.65 Million | ▼ -11.0 pp |
| 2021 | 257.5% | $9.15 Million | $3.56 Million | $10.56 Million | $1.41 Million | ▲ +311.8 pp |
| 2020 | -54.3% | $1.75 Million | $-3.21 Million | $9.28 Million | $7.54 Million | ▼ -150.9 pp |
| 2019 | 96.6% | $4.23 Million | $4.38 Million | $6.25 Million | $2.02 Million | ▼ -3.1 pp |
| 2018 | 99.7% | $4.01 Million | $4.03 Million | $5.65 Million | $1.63 Million | ▼ -170.7 pp |
| 2017 | 270.4% | $5.86 Million | $2.17 Million | $7.93 Million | $2.07 Million | ▲ +62.6 pp |
| 2016 | 207.8% | $7.87 Million | $3.79 Million | $9.28 Million | $1.41 Million | ▼ -14.1 pp |
| 2015 | 221.9% | $7.69 Million | $3.46 Million | $9.52 Million | $1.83 Million | ▲ +76.4 pp |
| 2014 | 145.6% | $13.38 Million | $9.19 Million | $15.25 Million | $1.87 Million | ▲ +41.0 pp |
| 2013 | 104.5% | $22.15 Million | $21.18 Million | $24.43 Million | $2.28 Million | ▲ +102.2 pp |
| 2012 | 2.3% | $-454.40K | $-19.66 Million | $116.01K | $570.41K | ▲ +5.5 pp |
| 2011 | -3.2% | $570.84K | $-17.65 Million | $905.34K | $334.50K | — |